aripiprazole has been researched along with Panic Attacks in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delong, HR; Hoge, EA; Kaufman, RE; Pollack, MH; Simon, NM; Worthington, JJ | 1 |
| Harada, T; Ishigooka, J; Sakamoto, K; Yamada, K | 1 |
| Lai, CH | 2 |
| Kollias, K; Konstantakopoulos, G; Nathanailidis, E; Oulis, P; Tsiamoura, M | 1 |
5 other study(ies) available for aripiprazole and Panic Attacks
| Article | Year |
|---|---|
Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Panic Disorder; Personality Inventory; Piperazines; Prospective Studies; Quinolones; Treatment Outcome | 2008 |
Aripiprazole augmentation for a patient with partial remission of panic disorder.
Topics: Adult; Agoraphobia; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Humans; Male; Panic Disorder; Paroxetine; Piperazines; Quinolones; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Aripiprazole-induced gray matter growth in a patient with major depressive disorder with panic disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain; Brain Mapping; Comorbidity; Depressive Disorder, Major; Female; Humans; Magnetic Resonance Imaging; Organ Size; Panic Disorder; Piperazines; Quinolones; Receptors, Serotonin | 2010 |
Aripiprazole-related subcortical growth in a patient with major depressive disorder and panic disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain; Depressive Disorder, Major; Humans; Male; Panic Disorder; Piperazines; Quinolones; Treatment Outcome | 2010 |
Low-dose aripiprazole in the treatment of selective serotonin reuptake inhibitors-induced orofacial and buccal dystonia.
Topics: Adult; Agoraphobia; Antipsychotic Agents; Aripiprazole; Dystonia; Face; Female; Humans; Panic Disorder; Paroxetine; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2012 |